- Report
- May 2025
- 181 Pages
Global
From €3115EUR$3,545USD£2,687GBP
€3461EUR$3,939USD£2,986GBP
- Training
- December 2024
- 2 Days
Global
From €1141EUR$1,298USD£984GBP
From €2614EUR$2,975USD£2,255GBP
€3075EUR$3,500USD£2,653GBP
- Training
- June 2024
- 90 Minutes
Global
- Training
- December 2023
- 2 Days
Global
From €2548EUR$2,900USD£2,198GBP
- Training
- April 2023
- 2 Days
Global
From €971EUR$1,105USD£837GBP
- Training
- 90 Minutes
Global
- Training
- 120 Minutes
Global
- Training
- 90 Minutes
Global
- Training
- 90 Minutes
Global
- Training
- 60 Minutes
Global
- Training
- 90 Minutes
Global
- Training
- 90 Minutes
Global
- Training
- 90 Minutes
Global
- Training
- 90 Minutes
Global
- Webinar
- 90 Minutes
Global
From €167EUR$190USD£144GBP

Post Marketing Surveillance (PMS) is a process used in the pharmaceutical manufacturing industry to monitor the safety and efficacy of drugs after they have been approved and released to the public. It involves collecting data from clinical trials, patient reports, and other sources to assess the safety and effectiveness of a drug. PMS also helps to identify any potential side effects or adverse reactions that may occur after a drug has been released. This data is then used to inform regulatory decisions and to ensure that the drug is safe and effective for its intended use.
PMS is an important part of the pharmaceutical manufacturing process, as it helps to ensure that drugs are safe and effective for their intended use. It also helps to identify any potential risks associated with a drug, allowing manufacturers to take corrective action if necessary.
Some companies in the PMS market include GlaxoSmithKline, Pfizer, Merck, Novartis, and Sanofi. Show Less Read more